BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11862424)

  • 1. Synergistic cytotoxic effect between serine-threonine phosphatase inhibitors and 5-fluorouracil: a novel concept for modulation of cytotoxic effect.
    Islam MM; Begum S; Lin L; Okamura A; Du M; Fujimura S
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):111-8. PubMed ID: 11862424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
    Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
    Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
    Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
    Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.
    Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA
    Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoprotein analysis for investigation of in vivo relationship between protein phosphatase inhibitory activities and acute hepatotoxicity of microcystin-LR.
    Tachi M; Imanishi SY; Harada K
    Environ Toxicol; 2007 Dec; 22(6):620-9. PubMed ID: 18000846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.
    Benz C; Choti M; Newcomer L; Cadman E
    Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors.
    Fladmark KE; Brustugun OT; Hovland R; Boe R; Gjertsen BT; Zhivotovsky B; Døskeland SO
    Cell Death Differ; 1999 Nov; 6(11):1099-108. PubMed ID: 10578179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects.
    Lawrence TS; Davis MA; Maybaum J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):519-23. PubMed ID: 8005809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells.
    Parker WB; Kennedy KA; Klubes P
    Cancer Res; 1987 Feb; 47(4):979-82. PubMed ID: 3802103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.